TMCnet News
Research and Markets: Global NGS (Next Generation Sequencing) Report to 2015DUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/rszh34/next_generation) has announced the addition of the "Global NGS (Next Generation Sequencing) Report to 2015" report to their offering. This second edition of the NGS report highlights two key topics, emerging adoption of NGS in clinical settings, as we expect 2015 to an inflection point for this market segment and the continued decentralization driven by desktop sequencers. Next generation sequencing (NGS) is a disruptive technology that allows scientists to sequence and assemble millions to billions of short DNA reads. This technology is used for applications such as whole genome sequencing, whole exome sequencing (1-2% of the genome that actually encodes proteins) or expression profiling. NGS is the fastest growing and the most attractive segment of the $7.1B genomics space (manufacturer market). With an estimated market size of -$1.2B in 2012, and a double digit growth rate, we forecast this market will reach $2.1B in 2015, driven by adoption in non-academic customers, especially clinical customers. NGS is poised to revolutionize not only medical research in academic laboratories and Biopharma, but also the healthcare landscape and applied markets (e.g., AgBio, food testing). The second edition of this report reviews the market size, segmentation, growth and trends of the NGS (and third generation sequencing) market. p> We assess the NGS market across 5 segments: company (Illumina, Life Technologies (Ion Torrent), Roche / 454 Life Sciences, Pacific BioSciences, and Others), product type (Instrument, Reagents, Services), customer (Academia, Biopharma, Applied Markets, Clinical, Other), instrument type (Workhorse, Desktop) and geography (U.S., Europe, Japan, Asia/Pacific, Others). For each of these segments, we provide an annual market size and growth from 2009 to 2015, as well as key growth drivers and moderators.In addition, we review major factors driving future growth including:
On the other hand, we discuss four key factors moderating growth including
Key Topics Covered: ABSTRACT EXECUTIVE SUMMARY INTRODUCTION What's new Context and methodology Genomics market overview NEXT GENERATION SEQUENCING MARKET Market overview Applications Market size and growth by product type Market size and growth by instrument type Market size and growth by company Market size and growth by customer base Market size and growth by geography Technology trends in genomics use COMPETITIVE ANALYSIS Illumina Life Technologies / Ion Torrent Roche / 454 Life Sciences Pacific Biosciences BGI / Complete Genomics DESKTOP SEQUENCER: ILLUMINA vs. ION TORRENT NEXT GENERATION SEQUENCING IN THE CLINIC APPENDIX For more information visit http://www.researchandmarkets.com/research/rszh34/next_generation
|